Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MEXC Program was a Singapore-based healthcare technology company founded in 2016 that aimed to modernize Emergency Medical Services (EMS) through the integration of blockchain technology. The company developed a comprehensive ecosystem for trauma management, featuring a pipeline of 25 patent-pending medical products including traumatology kits, infection control tools, and hemorrhage management devices. MEXC sought to utilize its proprietary "MEXC Token" to create a decentralized economy that would lower the cost of specialized EMS equipment and improve data transparency in pre-hospital care. Despite its ambitious goal to establish a global standard for EMS products and services, the company is currently inactive and classified as deadpooled. Its business model focused on bridging the gap between clinical innovation and affordable, accessible emergency care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MEXC.